OKKAMI is helping hotels and guests with contactless engagement, whilst still ensuring the hotel can deliver a high level of service.
“Our COVID-19 defense solution helps hotels to improve guest relations whilst reducing direct contact. As a result, this translates into an improved guest experience and a higher level of satisfaction when compared to a hotel that has not implemented a digital footprint,” said Andres Borbon, President & CTO of OKKAMI.
The OKKAMI COVID-19 product line provides hotels the necessary tools to save costs, generate revenue, and increase customer satisfaction whilst reducing contact points. These features are meant to provide hotels and guests with contactless engagement, while still ensuring the brand’s hospitality service standards are met. The selected key COVID-19 defense features that OKKAMI would like to introduce include contactless express check-in/out, mobile key, live chat, fulfillment request & staff ticketing system, digital menus, 3rd party sellers/stores within a brand app, room controls and promotions.
About OKKAMI
OKKAMI Inc. was founded in 2016 to cater to travelers and enhance all aspects of their journey. The company provides businesses in the hospitality industry with an IoT and guest engagement technology platform to better connect with customers, finalize transactions, and improve guest satisfaction. The platform also includes managed in-room devices in addition to downloadable apps for both iOS and Android. Visit https://www.okkami.com/ to learn more.
Let’s block ads! (Why?)
ZHENGZHOU, China--(BUSINESS WIRE)--In central China’s Zhengzhou city, visiting museums has become a new trend of…
Mollie Pearce, star of the UK reality TV show ‘The Traitors’ who was diagnosed with…
QBA 2024 Announces 35 Finalists Competing for Hong Kong's Highest Honour in the Building Industry…
SINGAPORE - Media OutReach Newswire - 17 May 2024 - UXLINK, the Web3 social platform…
DUBLIN--(BUSINESS WIRE)--The "Australia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to…
Three-part podcast interview features The mechanism of action of ANKTIVA® activating NK cells, Killer T…